Homo sapiens Protein: PEX1 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-381825.5 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | PEX1 | ||||||||||||||||||
Protein Name | peroxisomal biogenesis factor 1 | ||||||||||||||||||
Synonyms | PBD1A; PBD1B; ZWS; ZWS1; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000394413 | ||||||||||||||||||
InnateDB Gene | IDBG-26608 (PEX1) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Required for stability of PEX5 and protein import into the peroxisome matrix. Anchored by PEX26 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes. | ||||||||||||||||||
Subcellular Localization | Cytoplasm. Peroxisome membrane. Note=Associated with peroxisomal membranes. | ||||||||||||||||||
Disease Associations | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). {ECO:0000269PubMed:19105186}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum. PBD1A is an autosomal recessive systemic disorder characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269PubMed:9398847, ECO:0000269PubMed:9398848, ECO:0000269PubMed:9539740}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269PubMed:11439091, ECO:0000269PubMed:9398847, ECO:0000269PubMed:9539740}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 7 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR003593
AAA+ ATPase domain IPR003959 ATPase, AAA-type, core IPR008824 DNA helicase, Holliday junction RuvB type, N-terminal IPR009010 Aspartate decarboxylase-like domain IPR015342 Peroxisome biogenesis factor 1, N-terminal IPR015343 Peroxisome biogenesis factor 1, alpha/beta IPR027417 P-loop containing nucleoside triphosphate hydrolase IPR029067 CDC48 domain 2-like |
||||||||||||||||||
PFAM |
PF00004
PF07724 PF13304 PF05496 PF09262 PF09263 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00382
|
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O43933 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O43933 | ||||||||||||||||||
TrEMBL | Q96S70 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 5189 | ||||||||||||||||||
UniGene | Hs.164682 | ||||||||||||||||||
RefSeq | NP_001269606 | ||||||||||||||||||
HUGO | HGNC:8850 | ||||||||||||||||||
OMIM | 602136 | ||||||||||||||||||
CCDS | CCDS64710 | ||||||||||||||||||
HPRD | 03682 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AB008112 AB052090 AB052091 AB052092 AB052093 AB052094 AC000064 AC007566 AF026086 AF030356 AK292955 BC035575 CH236949 CH471091 | ||||||||||||||||||
GenPept | AAB46346 AAB87880 AAB99758 AAH35575 BAA85162 BAB59061 BAB59062 BAB59063 BAB59064 BAB59065 BAF85644 EAL24149 EAW76840 | ||||||||||||||||||